Belgia – Laboratooriumireaktiivid – Consolidatie kwaliteitscontrolemateriaal (QC) voor Klinische Chemie
Kirjeldus
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
See the translated text below.
CPV koodid
Dokumendid & esitamine
Contains data from Tenders Electronic Daily (TED), © European Union, ted.europa.eu — CC BY 4.0.
Seotud hanked
Belgium – Enterális tápszerek – Raamovereenkomst voor bij- en sondevoeding 2026-2030
AZ Delta vzwBelgiaEnteral feedsTähtajaks on 30 päevaAvaldatud 10. sept 2026
Belgium – A légzőrendszer gyógyszerei – LEVEREN VAN PIRFENIDONE 267 mg en 801 mg (filmomhulde) tabletten
UZ LeuvenBelgiaMedicinal products for the respiratory systemPharmaceutical productsVarious medicinal productsTähtajaks on 16 päevaAvaldatud 10. sept 2026
Belgium – Különböző gyógyszerek – infliximab IV - tocilizumab IV en SC - natalizumab IV - denosumab SC
EMMAUS VZWBelgiaVarious medicinal productsTähtajaks on 31 päevaAvaldatud 10. sept 2026
Belgium – Képalkotó berendezés orvosi, fogászati és állatorvosi használatra – Fourniture, livraison, montage, mise en service et maintenance d'une salle de coronarographie
ASBL GROUPE SANTE CHCBelgiaImaging equipment for medical, dental and veterinary useTähtajaks on 37 päevaAvaldatud 10. sept 2026